Allied Market Research

2024

Cancer Patient Registry Software Market

Cancer Patient Registry Software Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Deployment Model, by Functionality, by Database and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare IT

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cancer Patient Registry Software Market Outlook – 2027

Cancer patient registry software is a computerized database that is used for the organization, collection, and storing of the data of all the cancer patients for the evaluation of cancer-specific results, drug or medical device exposure, and conditions.

Cancer Patient Registry Software Market

Cancer Registry Software’s are kind of a disease registry that is used to maintain and also add a new cancer incidence reporting system. The cancer registry systems are often used as a resource where information is stored for cancer investigation and the possible causes of cancer.

These registries are very important as cancer is the most leading cause for the deaths and this collection of data on cancer cases helps right from the diagnosis to the survivorship which helps in identifying the trends to identify and help in improving patients' care and fighting against cancer.

COVID-19 scenario analysis:

With the outbreak of COVID-19 globally and the stipulated lockout, there is an ongoing downturn in the healthcare market. Aside from communities, COVID-19 was equally disastrous for major world economies, especially the healthcare sector. Prominent stakeholders are continuing to adapt their strategy to the rapidly changing situation. COVID-19 is projected to have significant long-term impacts on the healthcare industry. Countries and major players would have to undertake critical healthcare changes until the crisis takes a back seat.

Technological progress, cost containment, and increased access will in the near future be an integral part of healthcare reforms. Digital health and telehealth have taken a front seat in the ongoing outbreak. COVID-19 re-emphasized the importance of remote diagnosis, care, and consultation. Over the past few years, regulatory and behavioral barriers have slowed Telehealth growth. However, since many healthcare providers are currently working on video conferencing and telephone calls, this segment's growth will increase several folds over the next two years. The social distancing measures also mandated online consultation of patients with moderate symptoms. In addition, it greatly reduces the burden on hospitals already swamped by counts of COVID-19 patients. Medical IoT devices that live at home with patients are now being used for optimizing outpatient treatment and minimizing repeat visits, and these devices can be further used in a crisis situation. The pandemic led to severe resource constraints. This is expected to result in the development of competitive pricing and value-based pricing models, which will accelerate the market growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the Cancer Patient Registry Software market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

An increase in the frequency of cancer has been observed, government initiatives benefiting the users, growing pressure for the betterment of the patient care and reduction in the costs of healthcare, the adoption rate of HER increasing substantially, and increasing cancer patient registry software are the major factors propelling the growth of the cancer patient registry software market.

Governments of various countries are also focusing on awareness about cancer and health management of the population; healthcare costs coming down and coordinated care are some of the other factors affecting the growth of the cancer patient registry software market.

High pressure on the healthcare facilities of cancer, increasing funding by the government through initiatives for the encouragement of the cancer registries, healthcare IT sector has also been making high investments are also some of the other factors affecting the cancer patient registry software market positively.

Integration of registries of all the hospitals at one point-of-care, hospitals are participating in observational studies and utilize one data capture system to change their workflow for the accommodation of non-harmonized research demands.

New product launches and acquisitions to flourish the market:

On November 5th, 2018, Onco made advancements in their OncoLog Version 4.4.0 which includes the newest requirements asked by the NAACCR, AJCC, CoC, and SEER.

On January 31st, 2018, Elekta and IBM Watson Health collaborated to incorporate Watson for Oncology with Elekta’s cancer care solutions.

Surge in usage in research centers applications:

Research centers utilize the cancer patient registry software for tracking the patients' health and their eligibility for clinical trials. Researchers utilize this data for the development of new products as well. Some research centers maintain their records of the patients, and have segmented based on the cancer type they are suffering from. Apart from this, various research centers are also keeping up with the upgrades in cancer patient registry software with the help of healthcare associations and centers.

Key benefits of the report:

  • This study presents the analytical depiction of the global Cancer Patient Registry Software industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Cancer Patient Registry Software market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Cancer Patient Registry Software market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cancer Patient Registry Software Market research report:

  • What are the leading market players active in the Cancer Patient Registry Software market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

    Cancer Patient Registry Software Market Report Highlights

    Aspects Details
    icon_5
    By Type
    • Standalone Software
    • Integrated Software
    icon_6
    By Deployment Model
    • On-premise
    • Cloud-based
    icon_7
    By Functionality
    • Cancer Reporting to Meet State and Federal Regulations
    • Patient Care Management
    • Product Outcome Evaluation
    • Medical Research and Clinical Studies
    icon_8
    By Database
    • Commercial Databases
    • Public Databases
    icon_9
    By End User
    • Government Organizations andThird-party Administrators (TPAS)
    • Hospitals and Medical Practices
    • Pharmaceutical, Biotechnology, and Medical Device Companies
    • Private Payers
    • Research Centers
    icon_10
    By Region
    • North America  (U.S., Canada, Mexico)
    • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
    • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
    • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
    icon_11
    Key Market Players

    Conduent Inc, Elekta, Rocky Mountain Cancer Data Systems, Ordinal Data Inc., Onco, Inc., HimagineSolutions Inc., McKesson Corporation, IBM, C/Net Solutions, Electronic Registry Systems, Inc.

    Loading Table Of Content...

    Individual sections of the reports are available for purchase.
    Would you like to see a breakdown of prices by section?

    Cancer Patient Registry Software Market

    Global Opportunity Analysis and Industry Forecast, 2023-2032